bd-capital raises €430 million for Second Fund
14.3.2025 10:35:00 CET | Business Wire | Press release
bd-capital Fund 2 closes more than 20% above €350 million target Raised in under a year despite difficult market conditions bd-capital AUM reaches over €800 million
bd-capital, the pan-European, operator-led investment firm, is pleased to announce the final closing of its second fund, bd-capital Fund 2 (“Fund 2”), at €430 million. The fund closed more than 20% over its target of €350 million after less than twelve months in the market. With the closing of Fund 2, bd-capital’s assets under management have increased to over €800 million.
Commitments to Fund 2 were secured from a diverse cohort of institutional investors, including insurance companies, pension funds, sovereign wealth funds and family offices. In addition to Europe and the Middle East, a significant proportion of capital came from North American investors.
bd-capital’s Managing Partners, Andy Dawson and Richard Baker, said: “We are incredibly grateful for the continued support we have received from our existing limited partners and are delighted to have welcomed such a fantastic group of new investors into Fund 2. To have exceeded our fundraising target in a relatively short timeframe is a validation of our distinctive, operator-led, pan-European multi-sector specialist strategy. The firm continues to expand and with this new fund, we are well positioned to capitalise on the exciting opportunities in our target sub-sectors as we move onwards.”
bd-capital brings a highly differentiated investment approach to the European mid-market, utilising an operator-led strategy where its team of private equity investors and experienced business leaders work together in full partnership across all aspects of sourcing, diligence, execution and value creation.
bd-capital was supported by its partners at Houlihan Lokey (exclusive global placement agent), Weil, Gotshal & Manges (legal counsel), and Langham Hall (fund administration).
About bd-capital
Founded in 2019 by Andy Dawson (former Partner at Advent International), and Richard Baker (former FTSE 100 CEO and Chairman, and Advent Operating Partner), bd-capital employs an operator led investment strategy, making control investments in mid-market businesses headquartered in the UK, BeNeLux and Iberian markets which operate in subsectors that are experiencing enduring structural growth across Healthcare, Services and Consumer. bd-capital has offices in London, Amsterdam and Madrid.
Visit www.bd-cap.com to learn more.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250311630133/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting styrker sine tilbud inden for digital transformation og cybersikkerhed med HeadMind Partners15.6.2026 15:47:00 CEST | Pressemeddelelse
Andersen Consulting styrker sin platform gennem en samarbejdsaftale med HeadMind Partners, et førende europæisk konsulenthus med speciale i cybersikkerhed, digital transformation og ai. Med sin unikke kombination af 25 års erhvervserfaring og ekspertise inden for teknologi og data hjælper HeadMind Partners sine klienter – store virksomheder fra både den private og offentlige sektor – med at styrke deres digitale modstandskraft og cybersikkerhed, forbedre deres operationelle effektivitet og opbygge robuste og uafhængige ai-løsninger. Virksomheden har hovedsæde i Paris og opererer i dag i Frankrig og Belgien, hvor den trækker på multidisciplinære teams bestående af 500 cybersikkerhedseksperter, 70 ai-ingeniører og 400 specialister i digital transformation for at levere værdiskabende og friktionsfrie løsninger inden for cybersikkerhed, ai og digital transformation. HeadMind Partners betjener en mangfoldig og velanset kundeportefølje på tværs af industri-, energi- og luksusvaresektoren sam
Energy Dome and SRP to Add Long-Duration Energy Storage Project to the Grid, Expand Google Collaboration15.6.2026 15:30:00 CEST | Press release
The pilot will be part of Google and SRP’s effort to advance new non-lithium-ion long-duration energy storage technologies Energy Dome, a leading provider of innovative capacity solutions for utilities and AI infrastructure, and Salt River Project (SRP), a not-for-profit public power utility serving the greater Phoenix metropolitan area, today announced an agreement to add a 19 megawatt (MW), 10-hour carbon dioxide-based (CO2) battery system to the grid. The project is planned to be co-located on the site of SRP’s Coronado Generating Station (CGS) in St. Johns, Arizona, and it will be developed under a 20-year tolling agreement, with Energy Dome owning and operating the facility and SRP dispatching its output. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615027901/en/ Image: Rendering of Energy Dome’s energy storage system located at the Coronado Generating Station site The project is also part of Google and SRP’s innov
SLB Launches Digital Marketplace to Scale AI and Digital Innovation Across Energy15.6.2026 14:15:00 CEST | Press release
Curated marketplace connects energy professionals, developers and partners to discover, deploy and scale trusted AI agents, domain models and digital applications Global energy technology company SLB (NYSE: SLB) today announced the launch of the SLB Digital Marketplace, a curated digital destination designed to help energy companies rapidly discover and deploy specialized AI agents, domain models, skills, tools, data connectors and digital applications within their existing digital environments. The SLB Digital Marketplace extends the company’s open platform strategy to its Tela™ agentic AI assistant by enabling SLB, partners, independent software vendors (ISVs), developers and customers to bring purpose-built digital capabilities to the energy industry through a single, governed channel. All marketplace offerings are certified against SLB standards for security, interoperability and compatibility before listing. The launch comes as the industry moves toward agentic AI — where software
Thales at Eurosatory 2026: Ready today. Ready tomorrow15.6.2026 14:01:00 CEST | Press release
Thales pavilion (stand C247),Parc des Expositions, Paris Nord Villepinte, FranceMonday 15 to Friday 19 June, 2026. As Eurosatory 2026 opens its doors, Thales is pleased to share with you a complete overview of the announcements that will be made during the first day of this international defense and security show. This document centralises all our news, innovations and partnerships, released on June, 15th, 2026 with direct links to the associated press releases: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260615204020/en/ Thales at Eurosatory 2026: Ready today. Ready tomorrow.Thales unveils new AI-powered training data analytics platform to enhance military training.Thales launches next-generation 70mm laser-guided rocket dedicated for counter-drone operations.Thales unveils next-generation Bushmaster Mulga Utility Variant.Thales launches RapidStriker, a complete system for protection against drones.Renault Group and Thal
Biocytogen Earns Full AAALAC Accreditation, Reinforcing Excellence in Translational Research and Drug Discovery15.6.2026 14:00:00 CEST | Press release
Biocytogen today announced that its Boston research facility has been awarded Full Accreditation by AAALAC International, a globally recognized organization dedicated to promoting excellence in laboratory animal care and use. The accreditation reflects Biocytogen’s continued commitment to maintaining the highest standards of animal welfare, scientific integrity, and operational excellence across its preclinical research and drug discovery activities. Biocytogen’s Boston facility serves as a key hub supporting the company’s expanding portfolio of drug discovery and translational research capabilities. The facility enables a broad range of in vivo studies supporting antibody therapeutics, multispecific antibodies, ADCs, cell therapies, and other innovative biologics programs for pharmaceutical and biotechnology partners worldwide. Through its proprietary BioMice™ platform, Biocytogen has established one of the industry’s most comprehensive collections of genetically engineered disease mo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom